© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
January 18, 2016
Atrial fibrillation is characterized by abnormal impulse formations that cause the heart to beat irregularly.
August 11, 2015
Target-specific oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban are now being used in a larger and more diverse patient population.
March 12, 2015
The new target-specific oral anticoagulants, which include dabigatran, rivaroxaban, apixaban, and edoxaban have demonstrated safety and efficacy in the treatment of venous thromboembolism.
October 07, 2014